Olmetec elderly dose restriction lifted

The licence for Olmetec (olmesartan medoxomil) has been extended.

The licence now includes the use of 40mg daily in the elderly. Previously elderly patients were restricted to a maximum dose of 20mg due to a lack of available clinical data in this patient population.

If up-titration to the maximum dose of 40mg is required, blood pressure should be closely monitored.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more